Over 95 % of the pyridoxal phosphate (PLP) in skeletal muscle is bound to one protein, glycogen phosphorylase. This, and the fact that phosphorylase constitutes approx. 5 % of the soluble protein in skeletal muscle, introduce the possibility that PLP might be used as a specific label to identify degradation intermediates of the enzyme. In this investigation, we have developed immunological methods, using a monoclonal antibody to PLP and polyclonal antibodies to phosphorylase, to detect degradation intermediates in vitro and in vivo. We have identified a family of degradation intermediates of glycogen phosphorylase in the high-speed-supernatant fraction of mouse skeletal muscle. These peptides react with both types of antibodies and are in the size and concentration range expected for degradation intermediates in a model in which the committed step is followed by ra-pid clearance of the products. Changes in amounts of degradation intermediates are examined in physiological or pathological conditions in which the rate of degradation of phosphorylase is altered.
INTRODUCTION
Intracellular protein degradation converts a native protein inta its composite amino acids, and it is implicit that this process must require the sequential action of proteinases, initially generating large fragments but eventually yielding free amino acids. It follows that during the degradative processes intermediates must be formed by partial proteolysis (Beynon et al., 1985b) . In general, such intermediates have not been observed, implying that the first, committed, step in intracellular protein catabolism is considerably slower than subsequent steps . The late steps in degradation represent the clearance of functionally inactivated material and, as such, would be expected to be rapid. However, many studies in vitro have demonstrated that proteolytic attack on native proteins can proceed via discrete transient intermediates that contain relatively resistant domains (Price & Johnson, 1989) . Such investigations establish a precedent for low concentrations of discrete degradation intermediates in vivo.
Knowledge of the degradation intermediates could provide important information on the route(s) of catabolism of an intracellular protein, identifying proteolytically vulnerable areas of the molecule. Further, the intracellular localization of these intermediates would be valuable in identifying the subcellular sites of early stages of degradation. Identification of degradation intermediates in vivo is difficult. First, many of the peptides that are produced are devoid of properties that allow their identification. Secondly, it is to be expected that these intermediates exist at low levels in the cell, and therefore sensitive detection methods are needed. Western blots, with antibodies of the required affinity and selectivity, may provide that sensitivity.
There have been few studies that have attempted to identify degradation intermediates produced in vivo. The degradation of biotin-containing enzymes can be monitored with radiolabelled cofactor, and in cultured cell systems it has proved possible to demonstrate a family of biotinylated peptides, putatively derived from these enzymes (Chandler & Ballard, 1988) . However, the four biotin-enzymes are present in cells at similar levels, and it was not possible to assign the intermediates to one particular enzyme. Polyclonal antibodies have been used to identify degradation fragments of liver aldolase (Reznick et al., 1985) and phosphofructokinase (Toda & Ohashi, 1986) . The aldolase study may have been susceptible to degradation artefacts such as we have described (Cookson & Beynon, 1987) , whereas the phosphofructokinase study used purified enzyme, radilalbelled in vitro, to demonstrate the lack of artefactual degradation products.
Glycogen phosphorylase (EC 2.4.1.1; phosphorylase) has a number ofproperties that facilitate the analysis ofits degradation. First, it is present at high levels in skeletal muscle, constituting as much as 5 % of the soluble protein. Second, the enzyme is well understood in terms of structure (Fletterick & Madsen, 1980; Dombradi, 1980; Sansom et al., 1985) . The three-dimensional structures of the rabbit phosphorylases a and b are known to less than 0.3 nm resolution (Sprang & Fletterick, 1979; Sansom et al., 1985) . Finally, over 95 % of the pyridoxal phosphate (PLP) in skeletal muscle is associated with this enzyme. The cofactor can therefore be a specific probe for this enzyme, and we have used radiolabelled PLP to monitor the rate of degradation of the enzyme Cookson & Beynon, 1989) . The PLP is attached to a lysine residue (Lys-680 of a total of 841 amino acids in the rabbit muscle enzyme) approx. 800% along the primary sequence, and is buried deep within the phosphorylase structure. Removal of PLP from the holoenzyme is difficult (Shaltiel et al., 1967) , and thus PLP may remain attached to degradation intermediates. We have used a monoclonal antibody to PLP (Viceps-Madore et al., 1983) , in combination with polyclonal antibodies to muscle phosphorylase to search for degradation intermediates of this enzyme.
MATERIALS AND METHODS

Materials
Pure rabbit skeletal-muscle glycogen phosphorylase was provided by Professor P. Cohen Mice were maintained at 22-25°C on a 12 h-light/ 12 h-dark cycle and were allowed free access to food and water. In some animals, sciatectomy was performed on one hind limb as described previously (Leyland et al., 1990) 
Antibodies
The monoclonal antibody E6(4)1, highly specific for PLP, was prepared as described previously (Viceps-Madore et al., 1983) . Ascites fluid was used as a source of IgG without further purification. Affinity-purified rabbit antibodies to mouse phosphorylase were prepared as described previously (Cookson & Beynon, 1987) . A polyclonal antibody to pure chicken phosphorylase was raised in rabbits by an initial subcutaneous injection of 100 ,ug of chicken phosphorylase, purified to homogeneity by AMP-Sepharose affinity chromatography, followed by MonoQ ion-exchange chromatography. The antigen was injected in Freund's complete adjuvant; subsequently the animal was boosted by subcutaneous injection at two 6-weekly intervals, each with 100 #g of protein in Freund's incomplete adjuvant. PAGE SDS/PAGE was performed by the method of Studier (1973) . The 1.5 mm-thick gels consisted of a 12.5 % running gel and a 5 % stacking gel. Electrophoresis was for 3-4 h at 40 mA at 10 0C. After electrophoresis, parts of the gel were stained for protein or electroblotted on to nitrocellulose. In some instances, samples for electrophoresis were treated with 160 mM-NaCNBH3 for 10 min at 4 0C in the presence of 0.25 M-imidazole/citrate buffer, pH 6.0 (Shaltiel et al., 1967) (PBS-T) and a suitable dilution of antibody preparation. The monoclonal antibody was used at a dilution of ascites fluid of 1:250000, the rabbit anti-mouse phosphorylase serum at a dilution of 1: 500 and the rabbit anti-chicken phosphorylase serum at a dilution of 1:1000. The nitrocellulose was then washed three times in PBS-T (5 min/wash). Second antibody, i.e. horseradish peroxidaseconjugated rabbit anti-mouse immunoglobulin or goat antirabbit immunoglobulin, diluted 1:1000 in PBS-T, was incubated with the nitrocellulose for 1.5 h, followed by a further three washes in PBS-T (5 min/wash). Second antibody was detected by incubating the nitrocellulose for 10 min in PBS-T, containing 0.020% (w/v) with 160 mM-NaCNBH3 for 10 min gave substantial fixation of cofactor without artefactual fragmentation. In this respect NaCNBH3 is superior to the more reactive NaBH4. When phosphorylase is treated with either NaBH4 or NaCNBH3, the apparent molecular mass on SDS/PAGE increases (Fig. 2) . We have no explanation for this phenomenon, although retention of cofactor on the protein may interfere with SDS binding. The shift in mobility seems to be specific to phosphorylase (and has been observed with rabbit, mouse and chicken enzymes), and is a useful diagnostic tool for the identification of the protein and PLP-containing fragments.
Retention of PLP by degradation fragments
Detection of phosphorylase-derived peptides by the anti-PLP monoclonal antibody is only feasible if the cofactor remains attached to the products of proteolysis. A tryptic digest of phosphorylase (< 10 % residual activity) was monitored by Fast Green staining of protein bands in the polyacrylamide gel and by Western blots (Fig. 2) , either with an affinity-purified polyclonal antibody to mouse phosphorylase ('anti-phosphorylase'), or with a monoclonal antibody to PLP ('anti-PLP'). All tryptic peptides can be detected by the polyclonal antibody to the protein. After NaCNBH3 treatment most of the bands increase in mobility. Moreover, anti-PLP Western blotting demonstrates that many of these degradation intermediates contain PLP. The specificity of the monoclonal antibody is confirmed by the lane in which a sample was electrophoresed without reduction with NaCNBH3; no bands are visible. Some bands react with antiphosphorylase, but do not react with anti-PLP; these are peptides that have lost cofactor or which do not include the PLP-binding lysine. All peptides of molecular mass greater than about 78 kDa must contain the PLP-binding residue, and, as expected, peptides unreactive with the anti-PLP monoclonal antibody are all smaller than this. Fig. 2 also demonstrates the greater sensitivity of the anti-PLP antibody relative to the polyclonal antibody to the protein.
PLP remains attached to phosphorylase degradation products during proteolysis in vitro, and can be detected with the sensitivity and selectivity that might be applicable to studies of the degradation of the enzyme in vivo. However, the time scale of the proteolysis experiments in vitro is dramatically shorter (firstorder rate constant for inactivation = 1.38 h-') than the time frame for degradation of the enzyme in vivo. The first-order rate constant for phosphorylase degradation in mouse skeletal muscle is approx. 0.1 day-1 (Cookson & Beynon, 1989; Leyland et al., 1990; Leyland & Beynon, 1991 solved on SDS/PAGE and stained for protein, or immunoblotted with the anti-PLP monoclonal antibody. After exhaustive dialysis against hydroxylamine there was no further proteolytic digestion of phosphorylase, and PLP was still attached to phosphorylase and its degradation products (results not shown). Thus, degradation products possess sufficient higher-order structure to retain PLP even in the presence of a reagent that promotes dissociation. The requirement for higher-order structure was confirmed by dialysis against the same buffer containing 0.1 % (w/v) SDS; PLP was lost from all peptides (results not shown).
Specificity of labelling of phosphorylase in vivo by PLP PLP-labelled degradation intermediates of phosphorylase would be observed against a background of bands attributed to other PLP-binding proteins present in the tissue preparations. Thus the size distribution of PLP-containing proteins in vivo was assessed in liver and skeletal muscle, the two largest pools of PLP in the body. Soluble proteins from both tissues were prepared, immediately treated with NaCNBH3, separated by SDS/PAGE and blotted with the monoclonal antibody to PLP (Fig. 3) . Some non-specific binding of the antibody is seen both in liver and muscle preparations, but this is identifiable by the duplication of the bands in lanes that have not been treated with NaCNBH3.
Comparison of NaCNBH3-reduced samples with unreduced samples is a useful control that identifies non-specific bands on Western blots. Phosphorylase is not a major PLP-binding protein in liver, and the region of the blot in which degradation fragments would be expected is occupied by many other bands, attributable to both specific and non-specific effects. This contrasts with skeletal muscle, in which the great majority of PLP is bound to glycogen phosphorylase. In muscle preparations, some PLPproteins were identified at the lower molecular mass of 40-45 kDa; these are putatively aminotransferases.
PLP-labelled degradation intermediates of phosphorylase in skeletal muscle
In some blots, faint PLP-containing bands (for example, at approx. 70 kDa) could be seen (results not shown). These could be the products of intracellular degradation of phosphorylase. However, the heating of samples during preparation for SDS/PAGE can cause low-level fragmentation of proteins, the products of which might be misconstrued as products of proteolysis in vivo (Cookson & Beynon, 1987) . Accordingly, a muscle supernatant was exposed to different temperatures, and for various times, during sample preparation for SDS/PAGE (Fig. 4a) . Incubation at 100°C caused detectable fragmentation of phosphorylase, resulting in the progressive appearance of bands on the Western blot using anti-PLP (extreme right-hand lane of Fig. 4a ). At 60°C these PLP-peptides are not generated, but several bands in the 40-90 kDa range decrease in intensity during incubation at 60 'C. When a muscle supernatant fraction was treated with sample buffer at 4 'C and loaded at room temperature, the same peptides were present at higher concentrations and are therefore heat-labile. Although the nonspecific staining is worse in the absence of heat treatment, there was clear evidence of one strongly staining band of the same mobility as that seen at 60 'C (see lower arrow on Fig. 4a) , and a number of other faint bands that we believe are present in skeletal muscle in vivo. These PLP-containing bands are also visible on blots probed with affinity-purified anti-phosphorylase IgG and elicit the same response on heating (Fig. 4b) , which confirms that they are derived from phosphorylase in vivo. The anti-phosphorylase IgG also identifies bands on both NaCNBH3-treated and untreated samples, and these show the shift in mobility on reduction that is consistent with their derivation from phosphorylase.
These putative degradation intermediates are all in the range 60-70 kDa, although the NaCNBH3-induced shift in mobility precludes accurate estimates of size. These must be resistant phosphorylase fragments that retain sufficient structure to bind cofactor, and to survive in muscle. After section of the sciatic nerve in the mouse there is a marked wasting of the lower hind-limb muscles, and the specific activity of phosphorylase falls to approx. 300% of that of the contralateral control limb, which does not change. The decrease in phosphorylase content in the muscle is attributable in part to an accelerated degradation of the enzyme, from 0.12 to 0.20 day-1 (Leyland et al., 1990) . Degradation intermediates were determined in muscle at 10, 20 and 30 days after denervation. At these times, the phosphorylase activity as a percentage of that of the contralateral limb was 49 %, 30 % and 15 % respectively. There are no changes in phosphorylase expression in the contralateral limb over this period (Leyland et al., 1990) . At 10 days after denervation, the degradation intermediates were present in muscle at a higher concentration, but were of the same sizes as those in normal muscle (Fig. 5) . This implies that the accelerated removal of phosphorylase from denervated muscle is due to an increase in the activity of the sa-me degradative machinery that operates in normal muscle. Denervation-induced atrophy induces multiple proteolytic systems, and Furuno et al. (1990) have suggested that the degradation of cytosolic proteins in skeletal muscle is largely attributable to a non-lysosomal proteolytic system. This is consistent with our observation that there are no phosphorylase degradation intermediates in the particulate fraction ofmouse skeletal muscle (E. J. Cookson, unpublished work) . At 20 and 30 days after denervation, the levels of intermediates are much lower, consistent with the lower amount of phosphorylase in the muscle and a higher rate of degradation, which would combine to decrease the pool size of degradation fragments.
We have recently measured, by PLP-labelling, the rate of degradation of phosphorylase in the pectoralis muscle of broiler and layer chickens (Flannery et al., 1992) . This muscle grows extremely rapidly in broiler chickens, and over a 5-week period (from 3 to 8 weeks of age) the total pectoralis content of glycogen phosphorylase increases by 18-fold, from approx. 75 to 1400 mg. By contrast, in layer chickens, the same pool expands by 3-fold from approx. 100 to 270 mg over the same period. The major influence on accumulation of enzyme is the rate of synthesis, but the rate of degradation of the enzyme in 8-week-old animals in broilers is approximately twice that in layers. Accordingly, we examined the degradation intermediates in broiler and layer pectoralis muscle, using anti-PLP and a polyclonal antibody to chicken phosphorylase. Intermediates, similar to those seen in mouse muscle, were present in all samples (Fig. 6) confirmatory shift in mobility on NaCNBH3 reduction, a feature of all animal phosphorylases that we have examined, is also evident for these samples when blotted with the antiphosphorylase serum. The pattern of intermediates, which was essentially the same in broiler and layer muscle, implies that alterations in the rate of degradation of phosphorylase are elicited by changes in the activity of existing degradative processes, rather than by activation or suppression of complete systems. There were no obvious differences in the relative amounts of the intermediates in the muscle from the two strains.
The levels of these degradation products are very low. In isolated cells they can be increased by inclusion of proteinase inhibitors or lysosomotropic agents in media (Botbol & Scornick, 1983 ). Such manipulations are not possible in intact animals, and we estimate that in vivo the levels of phosphorylase-derived intermediates are substantially less than 1 % of the amount of intact protein. This has implications for the degradation kinetics of the enzyme, and reinforces the concept of a 'committed step' that is followed by rapid clearance of the committed protein molecule. It has been suggested that the multi-catalytic proteinase, or proteasome, may act by co-operativity between individual catalytic subunits, and that this might confer a degree of 'processivity' on proteolysis which might lead to degradation that was essentially complete after the protein was committed to destruction (Dick et al., 1991) . At present, we have no knowledge of the nature of the committed step for phosphorylase, which might include limited proteolysis, ubiquitin-mediated conjugation/proteolysis, release from a glycogen particle or sequestration into a different subcellular-compartment. However, irrespective of the nature of this step, it is apparent that the products, including the 70 kDa peptide(s), are removed from the muscle cell at a rate constant that could be at least two orders of magnitude greater than the rate of degradation. Although this is expected on teleological grounds, the mechanism whereby a protein can be committed slowly to a very rapid process remains unclear, but is one of the keys to an understanding of protein degradation.
